| J9271 | Injection, pembrolizumab, 1 mg | 11,600 | $40 | $487.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,060 | $90 | $91.4K |
| 78815 | PET and CT scans are both standard imaging tools that allow doctors to evaluate the location and metabolic actions of tumors or cancer inside the body before beginning an active treatment regimen.… | 50 | $1,040 | $46.9K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 17,330 | $1 | $34.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $90 | $29.6K |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 90 | $340 | $28.7K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,210 | $20 | $27.8K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 110 | $170 | $18.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 120 | $120 | $14.3K |
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 50 | $270 | $13.3K |